Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytokine therapeutics: lessons from interferon alpha

J U Gutterman1

  • 1Department of Clinical Immunology and Biological Therapy, University of Texas, M. D. Anderson Cancer Center, Houston 77030.

Proceedings of the National Academy of Sciences of the United States of America
|February 15, 1994
PubMed
Summary

Interferon (IFN)-alpha, a cytokine produced by recombinant DNA technology, regulates cell growth and immunity. Its broad efficacy in malignant, viral, and inflammatory diseases highlights its potential as a tumor suppressor and therapeutic protein.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A plant triterpenoid, avicin D, induces autophagy by activation of AMP-activated protein kinase.

Cell death and differentiation·2007
Same author

Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), suppress H-ras mutations and aneuploidy in a murine skin carcinogenesis model.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), inhibit activation of nuclear factor-kappaB by inhibiting both its nuclear localization and ability to bind DNA.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Triterpenoid saponins from Acacia victoriae (Bentham) decrease tumor cell proliferation and induce apoptosis.

Cancer research·2001
Same author

Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001
Same author

Avicins: triterpenoid saponins from Acacia victoriae (Bentham) induce apoptosis by mitochondrial perturbation.

Proceedings of the National Academy of Sciences of the United States of America·2001

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Cytokines mediate intercellular communication.
  • Interferon (IFN)-alpha, a recombinant cytokine, regulates cell growth, differentiation, and immune responses.
  • IFN-alpha impacts cellular signaling and immunological control.

Purpose of the Study:

  • To review the biological and clinical activities of Interferon (IFN)-alpha.
  • To discuss the spectrum of diseases where IFN-alpha shows efficacy.
  • To highlight IFN-alpha's role as a tumor suppressor protein.

Main Methods:

  • Review of existing literature on Interferon (IFN)-alpha.
  • Discussion of in vivo studies and clinical applications.
  • Analysis of IFN-alpha's mechanism in various diseases.

Related Experiment Videos

Main Results:

  • IFN-alpha demonstrates efficacy in malignant, viral, immunological, angiogenic, inflammatory, and fibrotic diseases.
  • Studies in hairy cell leukemia, chronic myelogenous leukemia, angiogenic diseases, and hepatitis illustrate its therapeutic principles.
  • IFN-alpha acts as a tumor suppressor, repressing tumorigenic phenotypes in differentiating malignancies.

Conclusions:

  • IFN-alpha has a broad therapeutic potential across diverse pathologies.
  • Its application in 13 malignant and viral disorders is approved globally.
  • IFN-alpha serves as a paradigm for developing natural protein therapeutics.